Unusual energy, irritability, little sleep, rapid thinking, or a period of depression can raise questions about bipolar disorder. Cocaine use can complicate that assessment because substance effects and mood symptoms may overlap. The right question is not whether one symptom proves bipolar disorder. It is how the symptoms developed over time, how they affected behavior and functioning, and what other explanations need consideration.

A careful assessment can recognize both an established bipolar illness and cocaine-related concerns. It can also acknowledge uncertainty when the available history does not yet support a clear conclusion. Immediate safety and treatment needs should still be addressed. Severe agitation, psychosis, inability to stay safe, or a medical emergency requires urgent help rather than waiting for a complete timeline.

Why the whole course matters more than one appointment

The NIMH bipolar disorder guide describes diagnosis as depending on the severity, duration, and frequency of symptoms and experiences across a person’s life, together with relevant family history. It also notes that prescribed and nonprescribed drugs can mimic or worsen mood symptoms. An assessment should therefore look beyond how someone appears during an intoxication, comedown, or single clinic visit.

Describe periods that felt markedly different from your usual state. Include changes in sleep need, activity, speech, judgment, spending, work, relationships, and mood. Do not assume a period was healthy simply because it felt productive or enjoyable. Equally, ordinary enthusiasm, a difficult night, or irritability by itself does not establish a manic or hypomanic episode.

Tell the clinician whether others noticed a change and whether there were consequences you recognized only later. If someone provides observations, separate what they saw from their interpretation. A report that you slept very little and made unusual financial decisions is more useful than a relative’s unsupported statement that you were definitely manic. The clinician should assess the pattern and context.

Build two connected timelines

Prepare a mood timeline and a substance-and-medication timeline. The first describes episodes and functioning; the second describes cocaine, other substances, prescriptions, and changes in use. Put them alongside each other without forcing a conclusion. The relationship may become clearer when periods before cocaine use and periods with different use patterns are included.

Timeline item Useful information to bring
Before the change Usual sleep, mood, functioning, medicines, and substance use.
During the change What changed, how long it continued, and what others observed.
Afterward What resolved, what persisted, and what treatment occurred.
Uncertainty Missing dates, unclear substance contents, or conflicting recollections.

Use approximate dates honestly. Hospital records, prescription records, earlier assessments, and messages or calendars you choose to review may help reconstruct events. You do not need to provide every private detail of your life. Ask the clinician which information is relevant, how it will be used, and whether a concise summary is sufficient for the next decision.

Our guide to discussing cocaine with a doctor can help with disclosure. Include alcohol, cannabis, sedatives, and prescribed stimulants as well as cocaine. A clinician needs to understand the combination, not only the substance that prompted the appointment. If you do not know what a nonprescribed product contained, record that uncertainty rather than guess.

Include episodes of depression even if the appointment was prompted by unusually high energy. A person may seek help only when feeling low and overlook earlier periods that felt productive. Conversely, a relative may focus on disruptive behavior and omit a prolonged period of withdrawal from ordinary life. Both perspectives can leave gaps. Ask the clinician to review the broader course and clarify which changes belong together as an episode.

Family history can contribute information, but it does not determine the diagnosis. Describe confirmed conditions separately from family descriptions such as mood swings or nervous breakdown. If you do not know the diagnosis or treatment involved, say so. A careful account of uncertainty is more useful than filling the gap with a familiar label.

Distinguish diagnostic uncertainty from a reason to delay help

The SAMHSA stimulant treatment guide describes psychiatric assessment as part of stimulant care. A working diagnosis may change as symptoms and substance use change. That does not mean the person should receive no care until a predetermined period has passed. Ask what can be treated or supported now and what requires continued observation.

For example, a clinician may need to address sleep disruption, severe distress, safety, or medication continuity while continuing to evaluate the mood history. The treatment of an acute problem and the final diagnostic explanation are related but distinct tasks. Ask the team to explain both so that a provisional label is not mistaken for either certainty or dismissal.

Avoid using a fixed number of days without cocaine as a personal diagnostic test. Symptoms, histories, and other substances vary. If a provider proposes reassessment after a period of stabilization, ask why that timing fits the circumstances, what will be monitored, and what should prompt earlier review. Significant deterioration should not be ignored because a planned review date has not arrived.

Know which changes call for urgent assessment

Tell a clinician promptly about major changes in behavior, markedly reduced sleep with unusual energy, altered perceptions, or decisions that are becoming dangerous. Describe the change rather than trying to choose the diagnosis first. If there is immediate danger to yourself or others, or you cannot remain safe, contact emergency services or go to emergency care.

Chest pain, a seizure, collapse, severe confusion, or serious breathing difficulty also requires urgent medical help. Cocaine use and an existing psychiatric diagnosis should not lead you to assume these symptoms are simply part of a mood episode. Medical and psychiatric assessment may both be needed, and the appropriate service should determine the current priorities.

Ask the treating team for an individualized plan for early warning signs and contact routes. With your consent, a trusted person can help recognize changes or support contact with care. Their role should be specific and realistic. They should not be expected to manage an acute mood episode alone or decide when medication needs changing without clinical advice.

Review established psychiatric treatment carefully

If bipolar disorder was diagnosed previously, bring the original assessment if available and explain the treatment course. Include which medicines helped, adverse effects, interruptions, and the reasons for any changes. An established diagnosis deserves attention, while new symptoms still need assessment. Neither automatically cancels the other part of the history.

Do not stop a mood-stabilizing or other psychiatric medicine on your own because you now suspect cocaine explained every earlier symptom. Equally, do not restart an old medicine to test whether it changes the current situation. NIMH advises discussing medication changes with the healthcare provider. The prescriber should review the diagnosis, current risks, and treatment response before deciding what to continue or alter.

Ask who coordinates psychiatric prescribing with cocaine treatment. Our medication evidence guide separates medicines for co-occurring conditions from claims about medication for cocaine use disorder. Each prescribed medicine should have a clear target, monitoring plan, and responsible clinician, including during a residential stay or transfer between services.

Plan cocaine treatment without losing the mood history

NIMH’s co-occurring disorders information supports considering substance use and mental health together. Ask how behavioral cocaine treatment will be adapted to current symptoms and functioning. The team should explain which work is appropriate now, which may need a different pace, and how progress will be reviewed with psychiatric care.

Identify situations that connect cocaine use with changes in activity, sleep, or judgment. The therapist can help examine the sequence and develop an appropriate response. Avoid assuming that every episode of use is driven by a mood disorder or that every mood change follows cocaine. The formulation needs to fit the individual pattern rather than a general story about the two conditions.

Discuss the daily structure you can realistically maintain, including sleep opportunities, appointments, work demands, and support. Ask the clinician which changes matter most for the current plan. A residential timetable may provide temporary structure, but the care team should also consider what happens when you return to ordinary responsibilities and how early changes will be recognized there.

Ask for a conclusion that separates findings from open questions

At the end of the assessment, ask what the clinician considers established, what remains provisional, and which alternatives are being considered. Request an explanation of the treatment recommendation in relation to those findings. You should understand why a particular setting, medication review, or therapy is proposed without needing to resolve all the diagnostic uncertainty yourself.

Agree how the timeline will be updated and who will review it. If another specialist opinion is recommended, confirm whether the referral is accepted and what care continues while you wait. The next step should include a date or contact process, not simply a suggestion to obtain more information at some undefined point in the future.

Before a handoff, make sure the receiving clinician gets the mood history, substance use history, current medicines, safety plan, and unresolved questions with appropriate consent. A careful bipolar assessment during cocaine care is a continuing clinical process. Its value lies in a clearer explanation and better coordinated treatment, not in obtaining a label as quickly as possible.

Sources and further reading

Found a detail that has changed? Tell the editorial team.